These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1683122)

  • 1. RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro.
    Liebermann H; Dölling R; Schmidt D; Thalmann G
    Acta Virol; 1991 Jan; 35(1):90-3. PubMed ID: 1683122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
    Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
    Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22].
    Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT
    Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and immunogenic properties of peptides--fragments of the immunodominant regions of the VP1 protein of the Asia-1 type of foot- and-mouth disease virus].
    Petrov VN; Rybakov SS; Petrova ON; Chepurkin AV; Gulenkin VM
    Bioorg Khim; 1998 Dec; 24(12):899-905. PubMed ID: 10079947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of an immunodominant loop on foot and mouth disease virus, serotype O1, determined under reducing conditions.
    Rowlands D; Logan D; Abu-Ghazaleh R; Blakemore W; Curry S; Jackson T; King A; Lea S; Lewis R; Newman J
    Arch Virol Suppl; 1994; 9():51-8. PubMed ID: 8032279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
    Fox G; Parry NR; Barnett PV; McGinn B; Rowlands DJ; Brown F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():625-37. PubMed ID: 2543752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
    Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
    Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
    J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is the Arg-Gly-Asp sequence the site for foot-and-mouth disease virus binding with cell receptor?].
    Surovoĭ AIu; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN; Driagalin NN
    Bioorg Khim; 1988 Jul; 14(7):965-8. PubMed ID: 2847760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
    Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
    Krebs O; Ahl R; Straub OC; Marquardt O
    Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus.
    Novella IS; Borrego B; Mateu MG; Domingo E; Giralt E; Andreu D
    FEBS Lett; 1993 Sep; 330(3):253-9. PubMed ID: 7690714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.
    Mason PW; Rieder E; Baxt B
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1932-6. PubMed ID: 8127909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67.
    Lea S; Abu-Ghazaleh R; Blakemore W; Curry S; Fry E; Jackson T; King A; Logan D; Newman J; Stuart D
    Structure; 1995 Jun; 3(6):571-80. PubMed ID: 8590018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
    Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
    Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of synthetic peptides for detection of antibodies against foot-and-mouth disease virus in the blood from convalescent animals].
    Petrov VN; Rybakov SS; Petrova ON; Lugovskoĭ AA; Pavlov AV
    Mol Gen Mikrobiol Virusol; 1996; (3):27-31. PubMed ID: 8999315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells.
    Leippert M; Beck E; Weiland F; Pfaff E
    J Virol; 1997 Feb; 71(2):1046-51. PubMed ID: 8995624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.